Amcor (AMCR) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
13 Jan, 2026Deal rationale and strategic fit
Creates a global leader in consumer and healthcare packaging with highly complementary portfolios, minimal overlap, and expanded product offerings.
Strengthens positions in high-growth, high-margin categories such as healthcare, protein, beauty, liquids, pet food, and food service.
Accelerates development of sustainable packaging solutions, with $180 million annual R&D spend, 10 innovation centers, and 1,500 R&D professionals.
Enhances ability to serve over 20,000 customers in 140+ countries, leveraging a combined workforce of 70,000 across 400 facilities.
Focuses on supply chain resilience, innovation, and proactive portfolio management in attractive growth and margin opportunities.
Financial terms and conditions
All-stock transaction with Berry shareholders receiving 7.25 Amcor shares per Berry share; Amcor and Berry shareholders will own approximately 63% and 37% of the combined company, respectively.
Combined revenues exceed $24 billion, with $4.3 billion in adjusted EBITDA and EBITDA margins of 18% (including synergies).
Transaction values Berry's common stock at $73.59 per share.
Amcor to maintain primary NYSE and secondary ASX listings; global head office in Zurich, significant U.S. presence.
Amcor entered a $3 billion bridge commitment to refinance part of Berry's debt and will assume the remainder at close; expected net leverage of 3.3x at close, with a path to de-lever below 3.0x within the first full year.
Synergies and expected cost savings
$650 million in annual synergies by year three, including $530 million from cost savings and $60 million from growth synergies.
$280 million in one-time cash benefits from working capital efficiencies, offsetting expected pre-tax integration costs.
Over 35% adjusted cash EPS accretion and double-digit ROI expected after three years.
Additional $100–$150 million in cost savings from Lean Transformation and digital initiatives are separate from identified synergies.
$60 million in annual run-rate financial savings.
Latest events from Amcor
- Strong Q2 and H1 growth from Berry acquisition; FY26 guidance reaffirmed amid integration.AMCR
Q2 20264 Feb 2026 - Q4 volumes returned to growth, driving strong FY24 cash flow and positive FY25 outlook.AMCR
Q4 20241 Feb 2026 - Net income up 26% to $191M on $3.35B sales, with margin gains and $122M asset sale to cut debt.AMCR
Q1 202517 Jan 2026 - Q2 net income up 22%, EPS up 23%, and Berry merger advances with $650M synergies targeted.AMCR
Q2 20259 Jan 2026 - Berry Global deal advances, synergies targeted, and margin growth continues amid cautious consumer trends.AMCR
Bank of America 2025 Global Agriculture and Materials Conference7 Jan 2026 - Fiscal 2024 saw strong earnings, board refreshment, and major advances in sustainability and governance.AMCR
Proxy Filing1 Dec 2025 - Merger integration, strong growth, and a proposed reverse stock split headline this year's proxy.AMCR
Proxy Filing1 Dec 2025 - Major merger, strong financials, and a 1-for-5 reverse stock split headline this year's proxy.AMCR
Proxy Filing1 Dec 2025 - Definitive proxy materials filed for shareholder voting, with no fee required.AMCR
Proxy Filing1 Dec 2025